The purpose of this project is to understand, from the perspective of medical providers and community health workers (CHWs), the barriers and facilitators that people released from prison experience in establishing and engaging with health care, and how those barriers and facilitators may be impacted by participation in the FIT and FIT Connect transitional health care programs.

The primary objective of the proposed project is to demonstrate the effects of limited physical facility infrastructure, diminished supplies, and gaps in Infection Prevention and Control (IPC) knowledge among Healthcare Personnel on IPC practice implementation at the health facility level to inform efficient and effective future improvement efforts.

The purpose of this project is to understand, from the perspective of formerly incarcerated individuals, the barriers and facilitators that people released from prison experience in establishing and engaging with health care, and how those barriers and facilitators may be impacted by participation in the FIT and FIT Connect transitional health care programs.

The SELIGO study assesses perceptions of HIV treatment - including long acting injectable antiretroviral therapy (LAI ART) - among people living with HIV infection (PLWH) and HIV healthcare providers (HCPs) to develop strategies and tools to facilitate shared decision-making by patients and provider considering HIV therapy options.

To study the use of long-acting injectable antiretroviral therapy (LAI) among a racially, economically, and geographically diverse group of persons with HIV

To test the pay-it-forward strategy as a means of increasing rates of testing for gonorrhea

To provide a much-needed characterization of Lassa fever epidemiology and pathogenesis, and to determine the duration and infectivity of genital fluids from survivors that will provide a wellspring of data to inform public policy and individual care.

The purpose of this study is to investigate if N-803, a new experimental drug that stimulates the immune system, is safe and tolerable when given alone and in combination with two new experimental drugs that are antibodies (natural proteins that the body makes in response to an infection) to HIV (the virus that causes AIDS), VRC07-523LS and 10-1074. This study will also look at how well HIV is controlled after stopping anti-HIV medications (also known as "ART") in persons who received N-803 alone or N-803 with VRC07-523LS and 10-1074.

The purpose of this research study is to learn more about patient preferences for care when undergoing treatment for drug use-associated endocarditis (DUA-IE), specifically treatment for addiction and antibiotic treatment.

This implementation science study will use mixed methods and an interrupted time series design to evaluate an implementation strategy intended to expand the reach and effectiveness of COVID-19 testing and vaccination services in underserved populations in the Piedmont region of NC. The primary service outcomes (i.e., reach and effectiveness) will be evaluated using review of existing routinely collected data. The primary implementation outcomes will be assessed through mixed methods research with patients who received, and providers who delivered, COVID-19 testing or prevention services, such as vaccination, at a Consortium-supported site such as a Federally Qualified Health Center administered by Piedmont Health. A standardized script will be used to inform potential participants about the study, their research options, and to screen to see if they are preliminarily eligible to take part in the study.